Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG-013736 plus gemcitabine versus gemcitabine in chemotherapy-naive advanced pancreatic cancer
2005-000053-30Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in pancreatic cancer (PC) and pancreatic adenocarcinoma (PDAC) comparing AG-013736 + gemcitabine with gemcitabine alone (2 arms). Primary endpoint: overall survival. Started Jun 2005; status: completed.
02
Drugs
axitinibgemcitabine
03
Conditions
pancreatic cancer (PC)pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on 2005-000053-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000053-30.